Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes
Twelve health organizations from around the US were selected to participate in a chart review Hypertension and Diabetes Initiative with the goal of improving blood pressure control in persons with diabetes.
A three-phase quality improvement initiative facilitated and monitored through the International Diabetes Center (IDC) will result in improved population-mean systolic blood pressure in the aggregate data pool of patients from all 12 participating sites at geographically distinct health systems.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Improving Hypertension Control in Individuals With Diabetes|
- Systolic blood pressure [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- Measure changes in action taken related to improving blood pressure management as percent of providers reporting changing (initiating or adjusting) blood pressure medication [ Time Frame: 1 year ] [ Designated as safety issue: No ]
|Study Start Date:||December 2006|
|Study Completion Date:||September 2010|
|Primary Completion Date:||May 2008 (Final data collection date for primary outcome measure)|
Other: quality improvement
Phase 1 - Preparation: Each participating site begins to organize itself for the project. Baseline data will be collected and will be used to benchmark where each site is relative to blood pressure control/management of persons with diabetes prior to the implementation of the training programs.
Phase 2 - Implementation: Sites begin to address the gaps they have identified that affect blood pressure outcomes of patients with diabetes. IDC provides two on-site training programs for providers and support staff.
Phase 3 - Follow-up: IDC provides on-going support to each site via individual and collaborative conference calls and resources on the project Web site. Patient and visit data (audit form) will be collected six and 12 months after training. This data will be compared to the site's pre-training data.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00743808
|Principal Investigator:||Margaret A Powers, PhD||International Diabetes Center - Park Nicollet Institute|
|Principal Investigator:||Robert M Cuddihy, MD||International Diabetes Center - Park Nicollet Institute|